The airway effects of stopping regular oral theophylline in patients with asthma

British Journal of Clinical Pharmacology

Volumn 45, Issue 4, 1998, Pages 402-404

  Bennett, J A ^a   Thompson Coon, J ^a   Pavord, I D ^a   Wilding, P J ^a   Tattersfield, A E ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Asthma; Lung function; Theophylline withdrawal

Indexed keywords

HISTAMINE; THEOPHYLLINE;

ADULT; ARTICLE; ASTHMA; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; FEMALE; FORCED EXPIRATORY VOLUME; HISTAMINE RELEASE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SPIROMETRY; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; ASTHMA; BRONCHOCONSTRICTION; BRONCHODILATOR AGENTS; CYCLIC AMP; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HISTAMINE; HUMANS; MALE; MIDDLE AGED; PLACEBOS; SUBSTANCE WITHDRAWAL SYNDROME; THEOPHYLLINE;

EID: 6844258217     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1998.00691.x     Document Type: Article

References (11)

1. Silverman K, Evans SM, Strain EC, Griffiths RR. Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Engl J Med 1992; 327: 1109-1114.
2. Stern M, Geddes DM, Collins JV, Evans T, Green M. Unstable asthma and theophylline. Br Med J 1991; 303: 1317-1319.
3. Kidney J, Dominguez M, Taylor PM, Rose M, Fan Chung K, Barnes PJ. Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy. Am J Respir Crit Care Med 1995; 151: 1907-1914.
4. Brenner M, Berkowitz R, Marshall N, Strunk RC. Need for theophylline in severe steroid-dependent asthmatics. Clin Allergy 1988; 18: 143-150.
5. Rabe KF, Magnussen H, Dent G. Theophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxants. Eur Respir J 1995; 8: 637-642.
6. Bachelet M, Vincent D, Havet N, Marrash-Chahla R, Pradalier A, Dry J, Vargaftig BB. Reduced responsiveness of adenylate cyclase in alveolar macrophages from patients with asthma. J Allergy Clin Immunol 1991; 88: 322-328.
7. Shuster L. Repression and de-repression of enzyme synthesis as a possible explanation of some aspects of drug action. Nature 1961; 189: 314-315.
8. Torphy TJ, Zhou HL, Cieslinski LB. Stimulation of beta-adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity. J Pharmacol Exp Ther 1992; 263: 1195-1205.
9. Aubier M, Levy J, Clerici C, Neukirch F, Cabrieres F, Herman D. Protective effect of theophylline on bronchial hyperresponsiveness in patients with allergic rhinitis. Am Rev Respir Dis 1991; 143: 346-350.
10. Barnes PJ, Pauwels RA. Theophylline in the management of asthma: time for reappraisal? Eur Respir J 1994; 7: 579-591.
11. Vathenen AS, Knox AJ, Wisniewski A, Tattersfield AE. Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma. Am Rev Respir Dis 1991; 143: 1317-1321.